Pfizer and BioNTech to Supply Japan with 120 Million Doses of their BNT162 mRNA-based Vaccine Candidate Read more
Sangamo Announces Global Collaboration With Novartis to Develop Genomic Medicines for Autism and Other Neurodevelopmental Disorders Read more
Pfizer and BioNTech Announce an Agreement with U.S. Government for up to 600 Million Doses of mRNA-based Vaccine Candidate Against SARS-CoV-2 Read more
Daiichi Sankyo and Gustave Roussy Enter Innovative Research Collaboration for DXd ADCs DS-1062 and Patritumab Deruxtecan Read more
Roche collaborates with Blueprint Medicines to bring a new treatment to people with RET-altered cancers Read more
TREMFYA Approved by FDA as the First Selective Interleukin (IL)-23 Inhibitor for Active Psoriatic Arthritis Read more